NEW Enterprise Associates 13 L.P., 10% Owner at PhaseBio Pharmaceuticals Inc (PHAS), sold 3,568,218 shares at $0.15 ($535K) on 2022-10-25, disclosed to the SEC on 2022-10-26.
Open-market sale of $535k PHAS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.15 | 1,784,109 | $268K | 50.0% |
| 2 | $0.15 | 1,784,109 | $268K | 50.0% |
| Total | $0.15 avg | 3,568,218 | $535K | 100% |
| Filing → |
| RARX | SELL | 2016-10-31 | $6K | — | Filing → |
| RARX | BUY | 2016-10-31 | $4.4M | — | Filing → |
| EPZM | BUY | 2016-01-12 | $10.0M | — | Filing → |